Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph 3 Nivolumab, or Nivolumab + Ipilimumab,vs platinum w/ Chemo-Naïve Stage IV/NSCLC.

Protocol: OSU-15127

Full Title

An Open-Label, Randomized Phase III Trial of Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus platinum doublet chemotherapy versus platinum doublet chemotherapy in Subjects with Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC).

Lung Cancers